Sicagen India Limited
Sicagen India Limited (SICAGEN.NS) Stock Competitors & Peer Comparison
See (SICAGEN.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial Materials Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SICAGEN.NS | ₹24.60 | +1.03% | 973.5M | -164.00 | -₹0.15 | +1.87% |
| VEDL.NS | ₹695.10 | +0.00% | 2.8T | 20.20 | ₹36.03 | +3.16% |
| VEDL.BO | ₹695.40 | +0.00% | 2.8T | 20.20 | ₹36.03 | +3.16% |
| HINDZINC.NS | ₹597.35 | +0.00% | 2.6T | 22.16 | ₹27.94 | +4.68% |
| HINDZINC.BO | ₹598.35 | +0.00% | 2.6T | 22.15 | ₹27.93 | +4.68% |
| MOIL.NS | ₹298.50 | +0.00% | 62.6B | 21.54 | ₹14.28 | +2.26% |
| MOIL.BO | ₹298.40 | +0.00% | 62.6B | 21.53 | ₹14.28 | +2.26% |
| ASHAPURMIN.NS | ₹531.20 | +0.00% | 52.2B | 13.83 | ₹39.54 | +0.18% |
| ASHAPURMIN.BO | ₹531.05 | +0.00% | 52.2B | 13.83 | ₹39.51 | +0.18% |
| ORISSAMINE.NS | ₹4,151.80 | +0.00% | 25.2B | -94.16 | -₹44.52 | N/A |
Stock Comparison
SICAGEN.NS vs VEDL.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, VEDL.NS has a market cap of 2.8T. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while VEDL.NS trades at ₹695.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas VEDL.NS's P/E ratio is 20.20. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to VEDL.NS's ROE of +0.31%. Regarding short-term risk, SICAGEN.NS is more volatile compared to VEDL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check VEDL.NS's competition here
SICAGEN.NS vs VEDL.BO Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, VEDL.BO has a market cap of 2.8T. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while VEDL.BO trades at ₹695.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas VEDL.BO's P/E ratio is 20.20. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to VEDL.BO's ROE of +0.31%. Regarding short-term risk, SICAGEN.NS is more volatile compared to VEDL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check VEDL.BO's competition here
SICAGEN.NS vs HINDZINC.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, HINDZINC.NS has a market cap of 2.6T. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while HINDZINC.NS trades at ₹597.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas HINDZINC.NS's P/E ratio is 22.16. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to HINDZINC.NS's ROE of +0.98%. Regarding short-term risk, SICAGEN.NS is more volatile compared to HINDZINC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check HINDZINC.NS's competition here
SICAGEN.NS vs HINDZINC.BO Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, HINDZINC.BO has a market cap of 2.6T. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while HINDZINC.BO trades at ₹598.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas HINDZINC.BO's P/E ratio is 22.15. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to HINDZINC.BO's ROE of +0.98%. Regarding short-term risk, SICAGEN.NS is more volatile compared to HINDZINC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check HINDZINC.BO's competition here
SICAGEN.NS vs MOIL.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, MOIL.NS has a market cap of 62.6B. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while MOIL.NS trades at ₹298.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas MOIL.NS's P/E ratio is 21.54. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to MOIL.NS's ROE of +0.11%. Regarding short-term risk, SICAGEN.NS is more volatile compared to MOIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check MOIL.NS's competition here
SICAGEN.NS vs MOIL.BO Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, MOIL.BO has a market cap of 62.6B. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while MOIL.BO trades at ₹298.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas MOIL.BO's P/E ratio is 21.53. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to MOIL.BO's ROE of +0.11%. Regarding short-term risk, SICAGEN.NS is more volatile compared to MOIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check MOIL.BO's competition here
SICAGEN.NS vs ASHAPURMIN.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, ASHAPURMIN.NS has a market cap of 52.2B. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while ASHAPURMIN.NS trades at ₹531.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas ASHAPURMIN.NS's P/E ratio is 13.83. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to ASHAPURMIN.NS's ROE of +0.31%. Regarding short-term risk, SICAGEN.NS is more volatile compared to ASHAPURMIN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check ASHAPURMIN.NS's competition here
SICAGEN.NS vs ASHAPURMIN.BO Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, ASHAPURMIN.BO has a market cap of 52.2B. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while ASHAPURMIN.BO trades at ₹531.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas ASHAPURMIN.BO's P/E ratio is 13.83. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to ASHAPURMIN.BO's ROE of +0.31%. Regarding short-term risk, SICAGEN.NS is more volatile compared to ASHAPURMIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check ASHAPURMIN.BO's competition here
SICAGEN.NS vs ORISSAMINE.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, ORISSAMINE.NS has a market cap of 25.2B. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while ORISSAMINE.NS trades at ₹4,151.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas ORISSAMINE.NS's P/E ratio is -94.16. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to ORISSAMINE.NS's ROE of +0.64%. Regarding short-term risk, SICAGEN.NS is more volatile compared to ORISSAMINE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check ORISSAMINE.NS's competition here
SICAGEN.NS vs ORISSAMINE.BO Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, ORISSAMINE.BO has a market cap of 25.1B. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while ORISSAMINE.BO trades at ₹4,150.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas ORISSAMINE.BO's P/E ratio is -65.09. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to ORISSAMINE.BO's ROE of +0.64%. Regarding short-term risk, SICAGEN.NS is more volatile compared to ORISSAMINE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check ORISSAMINE.BO's competition here
SICAGEN.NS vs JGCHEM.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, JGCHEM.NS has a market cap of 13.9B. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while JGCHEM.NS trades at ₹366.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas JGCHEM.NS's P/E ratio is 22.00. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to JGCHEM.NS's ROE of +0.13%. Regarding short-term risk, SICAGEN.NS is more volatile compared to JGCHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check JGCHEM.NS's competition here
SICAGEN.NS vs 20MICRONS.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, 20MICRONS.NS has a market cap of 6.2B. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while 20MICRONS.NS trades at ₹175.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas 20MICRONS.NS's P/E ratio is 9.57. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to 20MICRONS.NS's ROE of +0.15%. Regarding short-term risk, SICAGEN.NS is more volatile compared to 20MICRONS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check 20MICRONS.NS's competition here
SICAGEN.NS vs 20MICRONS.BO Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, 20MICRONS.BO has a market cap of 6.2B. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while 20MICRONS.BO trades at ₹176.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas 20MICRONS.BO's P/E ratio is 9.56. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to 20MICRONS.BO's ROE of +0.15%. Regarding short-term risk, SICAGEN.NS is more volatile compared to 20MICRONS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check 20MICRONS.BO's competition here
SICAGEN.NS vs SCFL.BO Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, SCFL.BO has a market cap of 5.9B. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while SCFL.BO trades at ₹26.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas SCFL.BO's P/E ratio is N/A. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to SCFL.BO's ROE of -0.05%. Regarding short-term risk, SICAGEN.NS is less volatile compared to SCFL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.NS.Check SCFL.BO's competition here
SICAGEN.NS vs EMAMIPAP.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, EMAMIPAP.NS has a market cap of 5.2B. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while EMAMIPAP.NS trades at ₹86.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas EMAMIPAP.NS's P/E ratio is 18.05. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to EMAMIPAP.NS's ROE of +0.05%. Regarding short-term risk, SICAGEN.NS is more volatile compared to EMAMIPAP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check EMAMIPAP.NS's competition here
SICAGEN.NS vs RAJMET.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, RAJMET.NS has a market cap of 1.1B. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while RAJMET.NS trades at ₹3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas RAJMET.NS's P/E ratio is -48.62. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to RAJMET.NS's ROE of -0.02%. Regarding short-term risk, SICAGEN.NS is more volatile compared to RAJMET.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check RAJMET.NS's competition here
SICAGEN.NS vs PATSPINLTD.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, PATSPINLTD.NS has a market cap of 436M. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while PATSPINLTD.NS trades at ₹14.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas PATSPINLTD.NS's P/E ratio is -3.18. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to PATSPINLTD.NS's ROE of +0.33%. Regarding short-term risk, SICAGEN.NS is more volatile compared to PATSPINLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check PATSPINLTD.NS's competition here
SICAGEN.NS vs IMPEXFERRO.BO Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, IMPEXFERRO.BO has a market cap of 149.5M. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while IMPEXFERRO.BO trades at ₹1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas IMPEXFERRO.BO's P/E ratio is -2.05. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to IMPEXFERRO.BO's ROE of +0.02%. Regarding short-term risk, SICAGEN.NS is more volatile compared to IMPEXFERRO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check IMPEXFERRO.BO's competition here
SICAGEN.NS vs IMPEXFERRO.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, IMPEXFERRO.NS has a market cap of 148.6M. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while IMPEXFERRO.NS trades at ₹1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas IMPEXFERRO.NS's P/E ratio is -2.04. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to IMPEXFERRO.NS's ROE of +0.02%. Regarding short-term risk, SICAGEN.NS is more volatile compared to IMPEXFERRO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check IMPEXFERRO.NS's competition here
SICAGEN.NS vs ARENTERP.BO Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, ARENTERP.BO has a market cap of 131.8M. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while ARENTERP.BO trades at ₹42.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas ARENTERP.BO's P/E ratio is -66.25. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to ARENTERP.BO's ROE of -0.00%. Regarding short-term risk, SICAGEN.NS is more volatile compared to ARENTERP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check ARENTERP.BO's competition here
SICAGEN.NS vs ARENTERP.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, ARENTERP.NS has a market cap of 125.4M. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while ARENTERP.NS trades at ₹42.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas ARENTERP.NS's P/E ratio is -63.02. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to ARENTERP.NS's ROE of -0.00%. Regarding short-term risk, SICAGEN.NS is less volatile compared to ARENTERP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.NS.Check ARENTERP.NS's competition here
SICAGEN.NS vs PRECISION.BO Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, PRECISION.BO has a market cap of 48.3M. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while PRECISION.BO trades at ₹54.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas PRECISION.BO's P/E ratio is -495.41. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to PRECISION.BO's ROE of +0.00%. Regarding short-term risk, SICAGEN.NS is less volatile compared to PRECISION.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.NS.Check PRECISION.BO's competition here
SICAGEN.NS vs METKORE.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, METKORE.NS has a market cap of 47.2M. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while METKORE.NS trades at ₹0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas METKORE.NS's P/E ratio is -0.40. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to METKORE.NS's ROE of -1.25%. Regarding short-term risk, SICAGEN.NS is less volatile compared to METKORE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.NS.Check METKORE.NS's competition here
SICAGEN.NS vs SEZAL.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, SEZAL.NS has a market cap of 0. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while SEZAL.NS trades at ₹5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas SEZAL.NS's P/E ratio is -0.00. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to SEZAL.NS's ROE of +0.15%. Regarding short-term risk, SICAGEN.NS is more volatile compared to SEZAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check SEZAL.NS's competition here
SICAGEN.NS vs ORIENTREF.NS Comparison February 2026
SICAGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SICAGEN.NS stands at 973.5M. In comparison, ORIENTREF.NS has a market cap of 0. Regarding current trading prices, SICAGEN.NS is priced at ₹24.60, while ORIENTREF.NS trades at ₹324.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SICAGEN.NS currently has a P/E ratio of -164.00, whereas ORIENTREF.NS's P/E ratio is 53.11. In terms of profitability, SICAGEN.NS's ROE is +0.04%, compared to ORIENTREF.NS's ROE of +0.22%. Regarding short-term risk, SICAGEN.NS is more volatile compared to ORIENTREF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.NS.Check ORIENTREF.NS's competition here